Phio Pharmaceuticals Corp. Earnings Per Share Diluted

Quick Answer

Phio Pharmaceuticals Corp. reported Earnings Per Share Diluted of $9.08 (loss) per share for the year ending 2024.

  • Phio Pharmaceuticals Corp. showed an increase of +80.6% in Earnings Per Share Diluted from 2023 to 2024.
  • This data is from Phio Pharmaceuticals Corp.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
  • XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2021 to 2024), Phio Pharmaceuticals Corp.'s Earnings Per Share Diluted has grown by 27.0%.
  • Historical annual values: Fiscal year 2024: $9.08 (loss) per share | Fiscal year 2023: $46.76 (loss) per share | Fiscal year 2022: $10.10 (loss) per share | Fiscal year 2021: $12.43 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: